Page 3 - Bio Pharma Reporter News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bio pharma reporter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bio Pharma Reporter Today - Breaking & Trending Today

CPHI Barcelona 2023: What are the key players doing?

With CPHI 2023 just around the corner, the pharma industry will soon descend on Barcelona for 3 jam-packed days of events, sessions and networking. ....

Comunidad Autonoma De Cataluna , Catalent Biologics , Samsung Biologics , Bio Pharma Reporter , Biopharma Culture , Samsung Biologics ,

Life sciences: which US regions are on the rise?

Throughout 2023, the life sciences industry has been faced with many operational issues, including supply-chain uncertainty, inflation, and talent shortages. ....

United Kingdom , United States , New Jersey , Princeton University , Chapel Hill , North Carolina , Duke University , Research Triangle Park , Rutgers University , New Hampshire , State Of New Jersey , South Korea , North Carolina State University , Eli Lilly , James Choi , Lonza Biologics , Fujifilm Diosynth , Samsung Biologics , William Bullock , Kathleen Coviello , Andrea Hechavarria , Phil Murphy , Thermo Fisher , Regenerative Manufacturing Institute , During Bio International , Boston Scientific ,

Samsung Biologics: James Choi on 'disrupting the market' through 'speed and innovation'

Last month, CDMO giant Samsung Biologics revealed it was planning to have its fifth plant operational by April 2025, five months earlier than previously anticipated. ....

South Korea , New Jersey , United States , James Choi , Moderna Spikevax , Samsung Biologics , Eli Lilly , Bio International , Bio Pharma Reporter , Bio Campus , Samsung Biologic ,

Lonza: 'We are platform and modality agnostic'

Earlier this month, Lonza acquired fellow biotech company Synaffix, to enhance and extend its integrated antibody-drug conjugates (ADCs) offering. ....

Jean Christophe Hyvert , Bio Pharma Reporter At International , Christophe Hyvert , Bio Pharma Reporter , Bio International ,

Women in Science: Katherine Vega Stultz on Ocelot's plans and fostering her 'CEO sisterhood' at Bio International

Katherine Vega Stultz is the CEO and president of Ocelot Bio, a clinical-stage biotech company focused on the development of therapeutics to treat complications of end-stage liver disease. ....

United States , Vega Stultz , Eli Lilly , Bio International , Bio Pharma Reporter At International , Bristol Myers Squibb , Graphite Bio , Bio Pharma Reporter , Ocelot Bio , Getty Images , Bio Developments , Biopharma Culture , Liver Disease , Clinical Trials ,